Adriano De Paula Sabino
Faculty of Pharmacy
Clinical and Toxicological Analysis
Federal University of Minas Gerais
Brazil
Biography
Pharmacist-Biochemist Clinical Analyst graduated from the Federal University of Ouro Preto (2002) with a Master's degree (2005) and PhD (2008) in Pharmaceutical Sciences by the Federal University of Minas Gerais. Has experience in the field of Pharmacy, with emphasis in Clinical / Molecular Hematology and Clinical Analysis Applied to the Study, Diagnosis and Therapy of Human Diseases, working mainly on the following topics: Haemostasis and Coagulation; Oncohematologia; Biomarker Laboratorial, Chemotherapy and Mechanism of Action of Bioactive Compounds. Coordinator and Full Advisor of the Postgraduate Program in Clinical and Toxicological Analysis, Masters and PhD levels. Currently Associate Professor at the Federal University of Minas Gerais.
Research Interest
Health Science Parasitology Microbiology
Publications
-
Evangelista, FCG ; BANDEIRA, MO; SILVA, GD; SILVA, MG; ANDRADE, SN; MARQUES, DR; SILVA, LM; CASTRO, WV ; SANTOS, FV; VIANA, GHR; VILLAR, JAFP; SABINO, AP ; VAROTTI, FP . Synthesis and in vitro evaluation of novel triazole / azide chalcones. Medicinal Chemistry Research (Print) , v. 1, p. 1-17, 2016.
-
CARVALHO, SS; SILVA, ACS; SABINO, AP ; Evangelista, FCG ; GOMES, KB; DUSSE, LMS ; RIOS, DRA . Influence of ACE I / D Polymorphism on Circulating Levels of Plasminogen Activator Inhibitor 1, D-Dimer, Ultrasensitive C-Reactive Protein and Transforming Growth Factor β1 in Patients Undergoing Hemodialysis. Plos One , v. 11, p. E0150613, 2016.
-
BRAGA, TV ; Evangelista, FCG ; GOMES, LC; ARAUJO, SSS; Carvalho, MG ; SABINO, AP . Evaluation of MiR-15a and MiR-16-1 as prognostic biomarkers in chronic lymphocytic leukemia. BIOMEDICINE & PHARMACOTHERAPY , v. 92, p. 864-869, 2017.
-
GOMES, LORENA CAIXETA; EVANGELISTA, FERNANDA CRISTINA GONTIJO; DE SOUSA, LIRLÂNDIA PIRES; DA SILVA ARAUJO, SERGIO SCHUSTERSCHITZ; OF THE GRAÇAS CARVALHO, MARIA; OF PAULA SABINO, ADRIANO . Prognosis biomarkers in chronic lymphocytic leukemia. Hematology / Oncology and Stem Cell Therapy, V. 1, p. 1, 2017.
